S

SoftOx Solutions AS
OSE:SOFTX

Watchlist Manager
SoftOx Solutions AS
OSE:SOFTX
Watchlist
Price: 0.0128 NOK -5.88% Market Closed
Market Cap: 25m NOK
Have any thoughts about
SoftOx Solutions AS?
Write Note

Relative Value

The Relative Value of one SOFTX stock under the Base Case scenario is 0.0237 NOK. Compared to the current market price of 0.0128 NOK, SoftOx Solutions AS is Undervalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SOFTX Relative Value
Base Case
0.0237 NOK
Undervaluation 46%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
22
Median 3Y
20.5
Median 5Y
47.1
Industry
2.6
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-6
Industry
23
vs History
vs Industry
7
Median 3Y
-5.1
Median 5Y
-6.6
Industry
17.8
vs History
vs Industry
Median 3Y
-4.7
Median 5Y
-6.2
Industry
25.4
vs History
vs Industry
3
Median 3Y
3.9
Median 5Y
5.6
Industry
2.2
vs History
98
vs Industry
15
Median 3Y
22.8
Median 5Y
40.7
Industry
2.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.4
vs History
vs Industry
54
Median 3Y
-3.4
Median 5Y
-4.8
Industry
13.7
vs History
vs Industry
51
Median 3Y
-2.9
Median 5Y
-4.5
Industry
17.2
vs History
vs Industry
5
Median 3Y
-4.6
Median 5Y
-6.2
Industry
16.5
vs History
vs Industry
40
Median 3Y
-4.5
Median 5Y
-5.8
Industry
19.3
vs History
98
vs Industry
61
Median 3Y
3.9
Median 5Y
5.8
Industry
2

Multiples Across Competitors

SOFTX Competitors Multiples
SoftOx Solutions AS Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
SoftOx Solutions AS
OSE:SOFTX
25.6m NOK 1.6 -0.3 -1 -0.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
746.8B USD 18.3 89.2 48 53.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
365.6B USD 4.2 24.9 12 15.7
US
Merck & Co Inc
NYSE:MRK
249.1B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.6B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.4B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.4 169.3 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
NO
S
SoftOx Solutions AS
OSE:SOFTX
Average P/E: 33.1
Negative Multiple: -0.3
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.2
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.9
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.4
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top